Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optive vs Systane with Restasis for Dry Eye
NCT00399061Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2006
- Primary completion
- Sep 2008
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carboxymethylcellulose sodium + glycerin, Optive, Systane in dry eye syndrome (DED), sponsored by Janssen Pharmaceutical. Started Nov 2006; status: completed.
02
Drugs
carboxymethylcellulose sodium + glycerinOptive, Systane
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00399061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399061.